Human cancers converge at the HIF-2α oncogenic axis
Aleksandra Franovic(Ondine Biopharma (United States)), Stephen Lee(University of Ottawa)
Cited by 126
Related Papers
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22–05): a single-arm, phase 1b–2 trial
|The Lancet Oncology|2020|190
Development of a Highly Sensitive Neurofilament Light Chain Assay on an Automated Immunoassay Platform
|Frontiers in Neurology|2022|42
From policy to action: how to operationalize the treatment for all agenda
|Journal of the International AIDS Society|2016|6